Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'dopamine transporter' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 952 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Correia, JDG; Domingos, A; Santos, I; Spies, H
      Synthesis and characterization of mixed-ligand oxorhenium(V) complexes with new [(PNO/S)(S)] donor atom sets

      JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS
    2. Curran, S; Mill, J; Tahir, E; Kent, L; Richards, S; Gould, A; Huckett, L; Sharp, J; Batten, C; Fernando, S; Ozbay, F; Yazgan, Y; Simonoff, E; Thompson, M; Taylor, E; Asherson, P
      Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples

      MOLECULAR PSYCHIATRY
    3. Rowe, DC; Stever, C; Chase, D; Sherman, S; Abramowitz, A; Waldman, ID
      Two dopamine genes related to reports of childhood retrospective inattention and conduct disorder symptoms

      MOLECULAR PSYCHIATRY
    4. Semwal, P; Prasad, S; Bhatia, T; Deshpande, SN; Wood, J; Nimgaonkar, VL; Thelma, BK
      Family-based association studies of monoaminergic gene polymorphisms amongNorth Indians with schizophrenia

      MOLECULAR PSYCHIATRY
    5. Nakamura, A; Inada, T; Kitao, Y; Katayama, Y
      Association between catechol-O-methyltransferase (COMT) polymorphism and severe alcoholic withdrawal symptoms in male Japanese alcoholics

      ADDICTION BIOLOGY
    6. Nass, R; Miller, DM; Blakely, RD
      C-elegans: a novel pharmacogenetic model to study Parkinson's disease

      PARKINSONISM & RELATED DISORDERS
    7. Purkerson-Parker, S; McDaniel, KL; Moser, VC
      Dopamine transporter binding in the rat striatum is increased by gestational, perinatal, and adolescent exposure to heptachlor

      TOXICOLOGICAL SCIENCES
    8. Faraone, SV; Doyle, AE
      The nature and heritability of attention-deficit/hyperactivity disorder

      CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA
    9. Chen, YK; Liu, RS; Huang, WS; Wey, SP; Ting, G; Liu, JC; Shen, YY; Wan, FJ
      The role of dopamine transporter imaging agent [Tc-99m]TRODAT-1 in hemi-parkinsonism rat brain

      NUCLEAR MEDICINE AND BIOLOGY
    10. Fowler, JS; Volkow, ND; Wang, GJ; Gatley, SJ; Logan, J
      [(11)]Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy

      NUCLEAR MEDICINE AND BIOLOGY
    11. Horton, N; Quick, MW
      Syntaxin 1A up-regulates GABA transporter expression by subcellular redistribution

      MOLECULAR MEMBRANE BIOLOGY
    12. Emond, P; Helfenbein, J; Chalon, S; Garreau, L; Vercouillie, J; Frangin, Y; Besnard, JC; Guilloteau, D
      Synthesis of tropane and nortropane analogues with phenyl substitutions asserotonin transporter ligands

      BIOORGANIC & MEDICINAL CHEMISTRY
    13. Neumeyer, JL; Gu, XH; van Vliet, LA; DeNunzio, NJ; Rusovici, DE; Cohen, DJ; Negus, SS; Mello, NK; Bidlack, JM
      Mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine abuse: Synthesis and opioid receptor binding affinity of N-substituted derivatives of morphinan

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    14. Liu, ZP; Wang, Y; Zhang, J; Ding, JG; Guo, LH; Cui, DF; Fei, JA
      Orphanin FQ: an endogenous antagonist of rat brain dopamine transporter

      NEUROREPORT
    15. Kawai, N; Honda, M; Nakamura, S; Samatra, P; Sukardika, K; Nakatani, Y; Shimojo, N; Oohashi, T
      Catecholamines and opioid peptides increase in plasma in humans during possession trances

      NEUROREPORT
    16. Liu, Z; Zhang, J; Fei, J; Guo, LH
      A novel mechanism of dopamine neurotoxicity involving the peripheral extracellular and the plasma membrane dopamine transporter

      NEUROREPORT
    17. Horschitz, S; Hummerich, R; Schloss, P
      Down-regulation of the rat serotonin transporter upon exposure to a selective serotonin reuptake inhibitor

      NEUROREPORT
    18. Barrett, AC; Morgan, D; Izenwasser, S; Picker, MJ
      Cocaine-like discriminative stimulus effects and [H-3]dopamine uptake inhibition produced by selected partial opioid agonists

      BEHAVIOURAL PHARMACOLOGY
    19. Collins, SL; Gerdes, RM; D'Addario, C; Izenwasser, S
      Kappa opioid agonists alter dopamine markers and cocaine-stimulated locomotor activity

      BEHAVIOURAL PHARMACOLOGY
    20. Rubia, K; Smith, A
      Attention deficit-hyperactivity disorder: current findings and treatment

      CURRENT OPINION IN PSYCHIATRY
    21. Holzschuh, J; Ryu, S; Aberger, F; Driever, W
      Dopamine transporter expression distinguishes dopaminergic neurons from other catecholaminergic neurons in the developing zebrafish embryo

      MECHANISMS OF DEVELOPMENT
    22. Stamenkovic, M; Schindler, SD; Asenbaum, S; Neumeister, A; Willeit, M; Willinger, U; de Zwaan, M; Riederer, F; Aschauer, HN; Kasper, S
      No change in striatal dopamine re-uptake site density in psychotropic drugnaive and in currently treated Tourette's disorder patients: a [I-123]-beta-CIT SPECT-study

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    23. Dean, B; Hussain, T
      Studies on dopaminergic and GABAergic markers in striatum reveals a decrease in the dopamine transporter in schizophrenia

      SCHIZOPHRENIA RESEARCH
    24. Laakso, A; Bergman, J; Haaparanta, M; Vilkman, H; Solin, O; Syvalahti, E; Hietala, J
      Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia

      SCHIZOPHRENIA RESEARCH
    25. Lavalaye, J; Linszen, DH; Booij, J; Dingemans, PMAJ; Reneman, L; Habraken, BAJ; Gersons, BPR; van Royen, EA
      Dopamine transporter density in young patients with schizophrenia assessedwith [(123)] FP-CIT SPECT

      SCHIZOPHRENIA RESEARCH
    26. Torres, GE; Yao, WD; Mohn, AR; Quan, H; Kim, KM; Levey, AI; Staudinger, J; Caron, MG
      Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1

      NEURON
    27. Donovan, DM; Nguyen, J; Revay, R; Liu, ZY; Rowley, DL; Barrett, T
      Murine dopamine transporter proximal promoter sequences do not direct lacZtransgene expression to ventral midbrain.

      NEUROSCIENCE RESEARCH COMMUNICATIONS
    28. Martinez, D; Gelernter, J; Abi-Dargham, A; van Dyck, CH; Kegeles, L; Innis, RB; Laruelle, M
      The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporterphenotype in humans

      NEUROPSYCHOPHARMACOLOGY
    29. Kish, SJ; Kalasinsky, KS; Derkach, P; Schmunk, GA; Guttman, M; Ang, L; Adams, V; Furukawa, Y; Haycock, JW
      Striatal dopaminergic and serotonergic markers in human heroin users

      NEUROPSYCHOPHARMACOLOGY
    30. Won, L; Bubula, N; McCoy, H; Heller, A
      Methamphetamine concentrations in fetal and maternal brain following prenatal exposure

      NEUROTOXICOLOGY AND TERATOLOGY
    31. Tsukada, H; Nishiyama, S; Kakiuchi, T; Ohba, H; Sato, K; Harada, N
      Ketamine alters the availability of striatal dopamine transporter as measured by [C-11]beta-CFT and [C-11]beta-CIT-FE in the monkey brain

      SYNAPSE
    32. Goulet, M; Miller, GM; Bendor, J; Liu, SH; Meltzer, PC; Madras, BK
      Non-amines, drugs without an amine nitrogen, potently block serotonin transport: Novel antidepressant candidates?

      SYNAPSE
    33. Navarro, HA; Xu, H; Zhong, D; Blough, BE; Ross, WP; Kuhar, MJ; Carroll, FI
      [(125) I]3 beta-(4-ethyl-3-iodophenyl)nortropane-2 beta-carboxylic acid methyl ester ([I-125]EINT): A potent and selective radioligand for the brain serotonin transporter

      SYNAPSE
    34. Callier, S; Morissette, M; Grandbois, M; Pelaprat, D; Di Paolo, T
      Neuroprotective properties of 17 beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice

      SYNAPSE
    35. Rinne, JO; Nurmi, E; Ruottinen, HM; Bergman, J; Eskola, O; Solin, O
      [F-18]FDOPA and [F-18]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease

      SYNAPSE
    36. Hayashi, T; Hirata, H; Asanuma, M; Ladenheim, B; Tsao, L; Cadet, JL; Su, TP
      Delta opioid peptide [D-Ala(2), D-Leu(5)]enkephalin causes a near completeblockade of the neuronal damage induced by a single high dose of methamphetamine: Examining the role of p53

      SYNAPSE
    37. Dutta, AK; Reith, MEA; Madras, BK
      Synthesis and preliminary characterization of a high-affinity novel radioligand for the dopamine transporter

      SYNAPSE
    38. Haapaniemi, TH; Ahonen, A; Torniainen, P; Sotaniemi, KA; Myllyla, VV
      [I-123]beta-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients

      MOVEMENT DISORDERS
    39. Tomkins, DM; Sellers, EM
      Addiction and the brain: the role of neurotransmitters in the cause and treatment of drug dependence

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    40. Hahn, IH; Hoffman, RS
      Cocaine use and acute myocardial infarction

      EMERGENCY MEDICINE CLINICS OF NORTH AMERICA
    41. Kalasinsky, KS; Bosy, TZ; Schmunk, GA; Reiber, G; Anthony, RM; Furukawa, Y; Guttman, M; Kish, SJ
      Regional distribution of methamphetamine in autopsied brain of chronic human methamphetamine users

      FORENSIC SCIENCE INTERNATIONAL
    42. Kimmel, HL; Carroll, FI; Kuhar, MJ
      Locomotor stimulant effects of novel phenyltropanes in the mouse

      DRUG AND ALCOHOL DEPENDENCE
    43. Camicioli, R; Lea, E; Nutt, JG; Sexton, G; Oken, BS
      Methylphenidate increases the motor effects of L-dopa in Parkinson's disease: A pilot study

      CLINICAL NEUROPHARMACOLOGY
    44. Saidi, M; Kothari, K; Pillai, MRA; Hassan, A; Sarma, HD; Chaudhari, PR; Unnikrishnan, TP; Korde, A; Azzouz, Z
      Cyclopentadienyl technetium (Tc-99m) tricarbonyl piperidine conjugates: biodistribution and imaging studies

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    45. Schirrmacher, R; Hamkens, W; Piel, M; Schmitt, U; Luddens, H; Hiemke, C; Rosch, F
      Radiosynthesis of (+/-)-(2-((4-(2-[F-18]fluoroethoxy)phenyl)bis(4-methoxy-phenyl) methoxy)ethylpiperidine-3-carboxylic acid: a potential GAT-3 PET ligand to study GABAergic neuro-transmission in vivo

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    46. Bolton, R
      Isotopic methylation

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    47. Mach, RH; Wheeler, KT; Blair, S; Yang, B; Day, CS; Blair, JB; Choi, SR; Kung, HF
      Preparation of a technetium-99m SPECT agent for imaging the sigma-2 receptor status of solid tumors

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    48. Gonzalez-Polo, RA; Mora, A; Clemente, N; Sabio, G; Centeno, F; Soler, G; Fuentes, JM
      Mechanisms of MPP+ incorporation into cerebellar granule cells

      BRAIN RESEARCH BULLETIN
    49. Thompson, TL; Bridges, SR; Weirs, WJ
      Alteration of dopamine transport in the striatum and nucleus accumbens of ovariectomized and estrogen-primed rats following N-(p-isothiocyanatophenethyl) spiperone (NIPS) treatment

      BRAIN RESEARCH BULLETIN
    50. Booij, J; Speelman, JD; Horstink, MWIM; Wolters, EC
      The clinical benefit of imaging striatal dopamine transporters with [I-123]FP-CIT SPET in differentiating patients with presynaptic parkinsonism fromthose with other forms of parkinsonism

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    51. Barthel, H; Sorger, D; Kuhn, HJ; Wagner, A; Kluge, R; Hermann, W
      Differential alteration of the nigrostriatal dopaminergic system in Wilson's disease investigated with [I-123]beta-CIT and high-resolution SPET

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    52. Ransmayr, G; Seppi, K; Donnemiller, E; Luginger, E; Marksteiner, J; Riccabona, G; Poewe, W; Wenning, GK
      Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    53. Maruyama, Y; Suzuki, Y; Kazusaka, A; Fujita, S
      Uptake of the dopaminergic neurotoxin, norsalsolinol, into PC12 cells via dopamine transporter

      ARCHIVES OF TOXICOLOGY
    54. Gasser, T
      Genetics of Parkinson's disease

      JOURNAL OF NEUROLOGY
    55. Markowitz, JS; Patrick, KS
      Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder

      CLINICAL PHARMACOKINETICS
    56. Freedman, LJ; Shi, C
      Monoaminergic innervation of the macaque extended amygdala

      NEUROSCIENCE
    57. Bezard, E; Boraud, T; Chalon, S; Brotchie, JM; Guilloteau, D; Gross, CE
      Pallidal border cells: An anatomical and electrophysiological study in the1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey

      NEUROSCIENCE
    58. Ivy, MT; Newkirk, RF; Karim, MR; Mtshali, CMP; Townsel, JG
      Hemicholinium-3 mustard reveals two populations of cycling choline cotransporters in Limulus

      NEUROSCIENCE
    59. Thompson, TL; Bridges, S; Miller, C
      Modulation of dopamine uptake in rat nucleus accumbens: effect of specificdopamine receptor antagonists and sigma ligands

      NEUROSCIENCE LETTERS
    60. Scholze, P; Sitte, HH; Singer, EA
      Substantial loss of substrate by diffusion during uptake in HEK-293 cells expressing neurotransmitter transporters

      NEUROSCIENCE LETTERS
    61. Rothblat, DS; Rubin, E; Schneider, JS
      Effects of chronic alcohol ingestion on the mesostriatal dopamine system in the rat

      NEUROSCIENCE LETTERS
    62. Ho, M; Segre, M
      Individual and combined effects of ethanol and cocaine on the human dopamine transporter in neuronal cell lines

      NEUROSCIENCE LETTERS
    63. Rubie, C; Schmidt, F; Knapp, M; Sprandel, J; Weigand, C; Meyer, J; Jungkunz, G; Riederer, P; Stober, G
      The human dopamine transporter gene: the 5 '-flanking region reveals five diallelic polymorphic sites in a Caucasian population sample

      NEUROSCIENCE LETTERS
    64. Zucker, M; Weizman, A; Harel, D; Rehavi, M
      Changes in vesicular monoamine transporter (VMAT2) and synaptophysin in rat substantia nigra and prefrontal cortex induced by psychotropic drugs

      NEUROPSYCHOBIOLOGY
    65. Winogrodzka, A; Bergmans, P; Booij, J; van Royen, EA; Janssen, AGM; Wolters, EC
      [I-123]FP-CIT SPECT is a useful method to monitor the rate of dopaminergicdegeneration in early-stage Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION
    66. Kemppainen, N; Marjamaki, P; Roytta, M; Rinne, JO
      Different pattern of reduction of striatal dopamine reuptake sites in Alzheimer's disease and ageing

      JOURNAL OF NEURAL TRANSMISSION
    67. Naudon, L; Leroux-Nicollet, I; Boulay, D; Costentin, J
      Decreased densities of dopamine and serotonin transporters and of vesicular monoamine transporter 2 in severely kainic acid lesioned subregions of the striatum

      JOURNAL OF NEURAL TRANSMISSION
    68. Drandarevski, N; Marburger, A; Walther, D; Reum, T; Uhl, G; Morgenstern, R
      Dopaminergic mRNA expression in the intact substantia nigra of unilaterally 6-OHDA-lesioned and grafted rats: an in situ hybridization study

      JOURNAL OF NEURAL TRANSMISSION
    69. Horschitz, S; Hummerich, R; Schloss, P
      Structure, function and regulation of the 5-hydroxytryptamine (serotonin) transporter

      BIOCHEMICAL SOCIETY TRANSACTIONS
    70. Lopez-Corcuera, B; Aragon, C; Geerlings, A
      Regulation of glycine transporters

      BIOCHEMICAL SOCIETY TRANSACTIONS
    71. Tella, SR; Goldberg, SR
      Subtle differences in the discriminative stimulus effects of cocaine and GBR-12909

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    72. Poyot, T; Conde, F; Gregoire, MC; Frouin, V; Coulon, C; Fuseau, C; Hinnen, F; Dolle, F; Hantraye, P; Bottlaender, M
      Anatomic and biochemical correlates of the dopamine transporter ligand C-11-PE2I in normal and parkinsonian primates: Comparison with 6-[F-18] Fluoro-L-Dopa

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    73. Letchworth, SR; Nader, MA; Smith, HR; Friedman, DP; Porrino, LJ
      Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys

      JOURNAL OF NEUROSCIENCE
    74. Walters, CL; Blendy, JA
      Different requirements for cAMP response element binding protein in positive and negative reinforcing properties of drugs of abuse

      JOURNAL OF NEUROSCIENCE
    75. Chen, BT; Rice, ME
      Novel Ca2+ dependence and time course of somatodendritic dopamine release:Substantia nigra versus striatum

      JOURNAL OF NEUROSCIENCE
    76. Bezard, E; Dovero, S; Prunier, C; Ravenscroft, P; Chalon, S; Guilloteau, D; Crossman, AR; Bioulac, B; Brotchie, JM; Gross, CE
      Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease

      JOURNAL OF NEUROSCIENCE
    77. Ranganathan, R; Sawin, ER; Trent, C; Horvitz, HR
      Mutations in the Caenorhabditis elegans serotonin reuptake transporter MOD-5 reveal serotonin-dependent and -independent activities of fluoxetine

      JOURNAL OF NEUROSCIENCE
    78. Chen, JJ; Li, ZS; Pan, H; Murphy, DL; Tamir, H; Koepsell, H; Gershon, MD
      Maintenance of serotonin in the intestinal mucosa and ganglia of mice thatlack the high-affinity serotonin transporter: Abnormal intestinal motilityand the expression of cation transporters

      JOURNAL OF NEUROSCIENCE
    79. Wade, TV; Schneider, JS
      Expression of striatal preprotachykinin mRNA in symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys is related to parkinsonian motor signs

      JOURNAL OF NEUROSCIENCE
    80. Herve, D; Le Moine, C; Corvol, JC; Belluscio, L; Ledent, C; Fienberg, AA; Jaber, M; Studler, JM; Girault, JA
      G alpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum

      JOURNAL OF NEUROSCIENCE
    81. Chen, JF; Xu, K; Petzer, JP; Staal, R; Xu, YH; Beilstein, M; Sonsalla, PK; Castagnoli, K; Castagnoli, N; Schwarzschild, MA
      Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in amodel of Parkinson's disease

      JOURNAL OF NEUROSCIENCE
    82. Wayment, HK; Schenk, JO; Sorg, BA
      Characterization of extracellular dopamine clearance in the medial prefrontal cortex: Role of monoamine uptake and monoamine oxidase inhibition

      JOURNAL OF NEUROSCIENCE
    83. Ralph, RJ; Paulus, MP; Fumagalli, F; Caron, MG; Geyer, MA
      Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: Differential effects of D1 and D2 receptor antagonists

      JOURNAL OF NEUROSCIENCE
    84. Sproson, EJ; Chantrey, J; Hollis, C; Marsden, CA; Fone, KCF
      Effect of repeated methylphenidate administration on presynaptic dopamine and behaviour in young adult rats

      JOURNAL OF PSYCHOPHARMACOLOGY
    85. Inazu, M; Kubota, N; Takeda, H; Oguchi, K; Koizumi, M; Kimura, S; Matsumiya, T
      Methyl-4-phenylpyridinium (MPP+)-evoked dopamine release from rat striatalslices: possible roles of voltage-dependent calcium channels and reverse dopamine transport

      NEUROCHEMISTRY INTERNATIONAL
    86. Barc, S; Page, G; Fauconneau, B; Barrier, L; Huguet, F
      A new in vitro approach for investigating the MPTP effect on DA uptake

      NEUROCHEMISTRY INTERNATIONAL
    87. Tzaferis, JA; McGinty, JF
      Kappa opioid receptor stimulation decreases amphetamine-induced behavior and neuropeptide mRNA expression in the striatum

      MOLECULAR BRAIN RESEARCH
    88. Ikeda, T; Kitayama, S; Morita, K; Dohi, T
      Nerve growth factor down-regulates the expression of norepinephrine transporter in rat pheochromocytoma (PC12) cells

      MOLECULAR BRAIN RESEARCH
    89. Corera, AT; Do-Rego, JC; Costentin, J; Bonnet, JJ
      Differential sensitivity to NaCl for inhibitors and substrates that recognize mutually exclusive binding sites on the neuronal transporter of dopamine in rat striatal membranes

      NEUROSCIENCE RESEARCH
    90. Ho, M; Segre, M
      Cloning and sequence analysis of cDNAs encoding the heavy and light chain variable regions of an Ab2 beta anti-idiotypic monoclonal antibody possessing an internal image of cocaine

      BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION
    91. Kiss, JP; Vizi, ES
      Nitric oxide: a novel link between synaptic and nonsynaptic transmission

      TRENDS IN NEUROSCIENCES
    92. Vila, M; Wu, DC; Przedborski, S
      Engineered modeling and them secrets of Parkinson's' disease

      TRENDS IN NEUROSCIENCES
    93. Deken, SL; Beckman, ML; Quick, MW
      PICKing on transporters

      TRENDS IN NEUROSCIENCES
    94. Bakker, JM; van Bel, F; Heijnen, CJ
      Neonatal glucocorticoids and the developing brain: short-term treatment with life-long consequences?

      TRENDS IN NEUROSCIENCES
    95. Amenta, F; Bronzetti, E; Cantalamessa, F; El-Assouad, D; Felici, L; Ricci, A; Tayebati, SK
      Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes

      JOURNAL OF NEUROIMMUNOLOGY
    96. Pan, YJ; Gembom, E; Peng, WP; Lesch, KP; Mossner, R; Simantov, R
      Plasticity in serotonin uptake in primary neuronal cultures of serotonin transporter knockout mice

      DEVELOPMENTAL BRAIN RESEARCH
    97. Eisenhofer, G
      The role of neuronal and extraneuronal plasma membrane transporters in theinactivation of peripheral catecholamines

      PHARMACOLOGY & THERAPEUTICS
    98. Huang, WS; Lin, SZ; Lin, JC; Wey, SP; Ting, G; Liu, RS
      Evaluation of early-stage Parkinson's disease with Tc-99m-TRODAT-1 imaging

      JOURNAL OF NUCLEAR MEDICINE
    99. Tzen, KY; Lu, CS; Yen, TC; Wey, SP; Ting, C
      Differential diagnosis of Parkinson's disease and vascular parkinsonism byTc-99m-TRODAT-1

      JOURNAL OF NUCLEAR MEDICINE
    100. Deterding, TA; Votaw, JR; Wang, CK; Eshima, D; Eshima, L; Keil, R; Malveaux, E; Kilts, CD; Goodman, MM; Hoffman, JM
      Biodistribution and radiation dosimetry of the dopamine transporter ligand[F-18]FECNT

      JOURNAL OF NUCLEAR MEDICINE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/12/19 alle ore 14:42:09